Lineage Cell Therapeutics logo
Lineage Cell Therapeutics LCTX
$ 0.51 -15.82%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Lineage Cell Therapeutics Operating Income 2011-2024 | LCTX

Annual Operating Income Lineage Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-6.36 M -6.64 M -28.2 M -26.4 M -38.9 M -41.8 M -38.9 M -59 M -65.8 M -50.7 M -56 M -25 M -18.7 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-6.36 M -65.8 M -35.6 M

Quarterly Operating Income Lineage Cell Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-3.84 M -5.87 M -6.66 M - -6.7 M -5.02 M -6.64 M - -5.25 M -4.23 M -6.4 M -28.2 M -6.84 M -7.08 M -7.05 M -5.88 M -6.72 M -6.4 M -7.44 M -6.87 M -8.42 M -10.8 M -12.8 M -10.1 M -10.4 M -9.14 M -12.2 M -9.56 M -9.51 M -8.56 M -11.3 M -11.3 M -9.56 M -14.4 M -23.8 M -21.7 M -17.1 M -13.5 M -13.5 M -14.4 M -12.1 M -13.1 M -11.1 M -29.3 M -10.2 M -8.12 M -8.38 M -7.06 M -5.95 M -6.08 M -5.92 M -5.45 M -4.23 M -4.98 M -4.03 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-3.84 M -29.3 M -9.83 M